- Voltijd
... and the UK, to develop innovative treatments for patients with cancer. Our haematology R&D group was born as Acerta Pharma, one of the Netherlands’ greatest biotech success stories. Its small-molecule BTK inhibitor has been approved by both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) ...
Aemstelredamme, Nederland